GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) » Definitions » Cyclically Adjusted Book per Share

Hubei Biocause Pharmaceutical Co (SZSE:000627) Cyclically Adjusted Book per Share : ¥3.66 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Hubei Biocause Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Hubei Biocause Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2024 was ¥4.159. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.66 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Hubei Biocause Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 8.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Hubei Biocause Pharmaceutical Co was 19.00% per year. The lowest was 6.20% per year. And the median was 12.80% per year.

As of today (2024-06-06), Hubei Biocause Pharmaceutical Co's current stock price is ¥1.95. Hubei Biocause Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥3.66. Hubei Biocause Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 0.53.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hubei Biocause Pharmaceutical Co was 15.13. The lowest was 0.59. And the median was 2.86.


Hubei Biocause Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Hubei Biocause Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Hubei Biocause Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 2.58 2.93 3.29 3.58

Hubei Biocause Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.37 3.42 3.52 3.58 3.66

Competitive Comparison of Hubei Biocause Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Insurance - Life subindustry, Hubei Biocause Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Biocause Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, Hubei Biocause Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hubei Biocause Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Hubei Biocause Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hubei Biocause Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.159/115.2271*115.2271
=4.159

Current CPI (Mar. 2024) = 115.2271.

Hubei Biocause Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.161 98.200 1.362
201409 1.139 98.900 1.327
201412 1.070 99.000 1.245
201503 1.056 99.900 1.218
201506 1.043 99.500 1.208
201509 1.030 100.500 1.181
201512 1.285 100.600 1.472
201603 2.968 102.200 3.346
201606 2.999 101.400 3.408
201609 3.168 102.400 3.565
201612 3.240 102.600 3.639
201703 3.242 103.200 3.620
201706 3.162 103.100 3.534
201709 2.826 104.100 3.128
201712 3.914 104.500 4.316
201803 3.896 105.300 4.263
201806 3.829 104.900 4.206
201809 3.814 106.600 4.123
201812 3.844 106.500 4.159
201903 4.103 107.700 4.390
201906 4.116 107.700 4.404
201909 4.115 109.800 4.318
201912 4.296 111.200 4.452
202003 4.288 112.300 4.400
202006 4.218 110.400 4.402
202009 4.209 111.700 4.342
202012 4.278 111.500 4.421
202103 4.354 112.662 4.453
202106 4.351 111.769 4.486
202109 4.531 112.215 4.653
202112 4.565 113.108 4.651
202203 4.376 114.335 4.410
202206 4.437 114.558 4.463
202209 4.296 115.339 4.292
202212 4.334 115.116 4.338
202303 4.402 115.116 4.406
202306 4.232 114.558 4.257
202309 4.174 115.339 4.170
202312 4.167 114.781 4.183
202403 4.159 115.227 4.159

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Hubei Biocause Pharmaceutical Co  (SZSE:000627) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hubei Biocause Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.95/3.66
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hubei Biocause Pharmaceutical Co was 15.13. The lowest was 0.59. And the median was 2.86.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Hubei Biocause Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000
Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.
Executives
Jiang Hai Hua Independent director
Fu Yong Jin Directors, executives
Wu Shi Yan Supervisors

Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines

No Headlines